David Sullivan

17.7k total citations · 5 hit papers
211 papers, 11.8k citations indexed

About

David Sullivan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Sullivan has authored 211 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Surgery, 57 papers in Endocrinology, Diabetes and Metabolism and 43 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Sullivan's work include Lipoproteins and Cardiovascular Health (92 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers) and Cancer, Lipids, and Metabolism (29 papers). David Sullivan is often cited by papers focused on Lipoproteins and Cardiovascular Health (92 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers) and Cancer, Lipids, and Metabolism (29 papers). David Sullivan collaborates with scholars based in Australia, New Zealand and United States. David Sullivan's co-authors include Philip J. Barter, Russell Scott, James D. Best, Paul Glasziou, David Hunt, R. John Simes, Marja‐Riitta Taskinen, Christian Ehnholm, M.J. Whiting and Timothy M. E. Davis and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

David Sullivan

202 papers receiving 11.3k citations

Hit Papers

Effects of long-term fenofibrate therapy on cardiovascula... 2005 2026 2012 2019 2005 2006 2014 2014 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
    2005 2.4k citations Philip J. Barter, James D. Best et al. profile →
  2. Health benefits of herbs and spices: the past, the present, the future
    2006 717 citations David Sullivan, Peter Clifton et al. The Medical Journal of Australia profile →
  3. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
    2014 562 citations Frederick J. Raal, Traci Turner et al. profile →
  4. Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
    2014 421 citations David Colquhoun, David Sullivan et al. Journal of the American College of Cardiology profile →
  5. Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
    2012 369 citations David Sullivan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sullivan Australia 53 5.5k 3.6k 2.5k 2.0k 1.4k 211 11.8k
L. Masana Spain 49 4.6k 0.8× 3.0k 0.8× 2.4k 0.9× 2.2k 1.1× 827 0.6× 376 10.0k
Željko Reiner Croatia 47 6.8k 1.2× 3.7k 1.0× 3.8k 1.5× 1.5k 0.8× 1.8k 1.3× 265 13.3k
Dimitri P. Mikhailidis United Kingdom 59 6.2k 1.1× 3.4k 1.0× 3.4k 1.4× 1.8k 0.9× 830 0.6× 421 14.8k
Paul N. Durrington United Kingdom 68 7.6k 1.4× 6.6k 1.8× 3.3k 1.3× 2.6k 1.3× 1.6k 1.1× 287 19.9k
John R. Guyton United States 53 6.2k 1.1× 3.3k 0.9× 2.5k 1.0× 1.7k 0.9× 995 0.7× 166 12.0k
Michel Krempf France 45 5.4k 1.0× 3.7k 1.0× 1.2k 0.5× 2.1k 1.0× 1.1k 0.8× 264 11.0k
Jiří Fröhlich Canada 51 4.8k 0.9× 3.8k 1.1× 2.3k 0.9× 1.4k 0.7× 546 0.4× 166 10.2k
Peter P. Tóth United States 68 8.4k 1.5× 5.4k 1.5× 3.9k 1.5× 2.2k 1.1× 1.8k 1.3× 529 16.7k
Maurizio Averna Italy 45 5.2k 0.9× 2.9k 0.8× 2.8k 1.1× 1.2k 0.6× 1.0k 0.7× 288 9.6k
M. John Chapman France 50 8.2k 1.5× 5.6k 1.6× 3.3k 1.3× 2.2k 1.1× 1.3k 0.9× 134 14.1k

Countries citing papers authored by David Sullivan

Since Specialization
Citations

This map shows the geographic impact of David Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sullivan more than expected).

Fields of papers citing papers by David Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sullivan. The network helps show where David Sullivan may publish in the future.

Co-authorship network of co-authors of David Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of David Sullivan. A scholar is included among the top collaborators of David Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sullivan. David Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tang, Owen, Michael P. Gray, S A Vernon, et al.. (2025). Evaluating the role of lipoprotein(a) in enhancing risk stratification for the presence and extent of subclinical coronary artery disease burden: a BioHEART-CT study. European Journal of Preventive Cardiology. 3 indexed citations
3.
Sullivan, David, Andrew Partington, Charlotte Hespe, et al.. (2024). Preliminary Results From the Implementation of a Primary-Tertiary Shared Care Model to Improve the Detection of Familial Hypercholesterolaemia (FH): A Mixed Methods Pre-Post Implementation Study. Heart Lung and Circulation. 33. S315–S315. 1 indexed citations
4.
Sullivan, David, Shubha Srinivasan, Andrew Partington, et al.. (2024). Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol. BMJ Open. 14(5). e082699–e082699. 3 indexed citations
5.
O’Rourke, Matthew B., Andrzej S. Januszewski, David Sullivan, et al.. (2023). Optimised plasma sample preparation and LC‐MS analysis to support large‐scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. PROTEOMICS - CLINICAL APPLICATIONS. 17(3). e2200106–e2200106. 8 indexed citations
6.
Sarkies, Mitchell, Luke Testa, Stephanie Best, et al.. (2023). Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia. Heart Lung and Circulation. 32(11). 1347–1353. 6 indexed citations
7.
Ward, Natalie C., Gerald F. Watts, Warrick Bishop, et al.. (2023). Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. Heart Lung and Circulation. 32(3). 287–296. 14 indexed citations
8.
Marquina, Clara, Jedidiah I Morton, Tom Brett, et al.. (2023). Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment. Circulation Genomic and Precision Medicine. 16(3). 267–274. 2 indexed citations
9.
Brett, Tom, Dick C. Chan, Jan Radford, et al.. (2021). Improving detection and management of familial hypercholesterolaemia in Australian general practice. Heart. 107(15). 1213–1219. 15 indexed citations
10.
11.
Ward, Natalie C., Karam Kostner, David Sullivan, Paul J. Nestel, & Gerald F. Watts. (2019). Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?. Journal of Clinical Medicine. 8(12). 2073–2073. 18 indexed citations
12.
Hovingh, G. Kees, Frederick J. Raal, Ricardo Dent, et al.. (2017). Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia. Journal of clinical lipidology. 11(6). 1448–1457. 48 indexed citations
13.
Peiris, David, Tim Usherwood, Julie Redfern, et al.. (2017). Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative. The Medical Journal of Australia. 206(10). 436–441. 11 indexed citations
14.
Sullivan, David. (2016). The Breeding and Non-Breeding Behaviour of the Hooded Robin Melanodryas cucullata in Canberra, 1990-1991. Australian field ornithology. 15(3).
15.
Mundra, Piyushkumar A., Christopher K. Barlow, Paul J. Nestel, et al.. (2016). Abstract 17413: Plasma Lipidomic Profiles in Two Large Independent Cohorts Improve Upon Conventional Risk Factors to Predict Cardiovascular Events. Circulation. 134. 1 indexed citations
16.
Phillips, Craig L., Brendon J. Yee, Nathaniel S. Marshall, et al.. (2011). Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Crossover Trial. American Journal of Respiratory and Critical Care Medicine. 184(3). 355–361. 106 indexed citations
17.
Webster, Ruth, et al.. (2010). Effects Of Internet-Based Tailored Advice on the Use of Cholesterol-Lowering Interventions: A Randomized Controlled Trial. Journal of Medical Internet Research. 12(3). e42–e42. 12 indexed citations
18.
Gonzalo, María José, Marin T. Brewer, Claire Anderson, et al.. (2009). Tomato Fruit Shape Analysis Using Morphometric and Morphology Attributes Implemented in Tomato Analyzer Software Program. Journal of the American Society for Horticultural Science. 134(1). 77–87. 89 indexed citations
19.
Tonkin, Andrew, Philip J. Barter, James D. Best, et al.. (2005). National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Heart Lung and Circulation. 14(4). 55 indexed citations
20.
Raitakari, Olli T., et al.. (2000). Enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology. 36(2). 417–422. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Masana Breakdown of academic impact, for papers by Željko Reiner Breakdown of academic impact, for papers by Dimitri P. Mikhailidis Breakdown of academic impact, for papers by Paul N. Durrington Breakdown of academic impact, for papers by John R. Guyton Breakdown of academic impact, for papers by Michel Krempf Breakdown of academic impact, for papers by Jiří Fröhlich Breakdown of academic impact, for papers by Peter P. Tóth Breakdown of academic impact, for papers by Maurizio Averna Breakdown of academic impact, for papers by M. John Chapman
Rankless by CCL
2026